A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The objective of the study was to study the effects of donepezil on cognition in patients with schizophrenia. The investigators conducted a 12-week, double-blind, placebo-controlled trial of donepezil as adjunctive treatment to antipsychotic drugs on patients with schizophrenia.
Epistemonikos ID: 119a599cd3a8b8f246f10c34a0e70250f4e40271
First added on: May 10, 2024